FDA Yanks Rule Shielding Docs In Misconduct Inquiries

Law360, New York (January 11, 2013, 3:36 PM EST) -- Citing stiff opposition, the U.S. Food and Drug Administration on Thursday withdrew a proposal to keep under wraps certain documents related to misconduct investigations of researchers, but the plan appears far from dead.

The agency said it received “significant adverse comment” in response to the proposal, which would create exemptions from Privacy Act disclosure requirements, but declined a request to elaborate. The Federal Register shows that four comments were submitted on the plan, but the comments weren’t immediately available.

When the plan was unveiled in August,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.